LABORATORIO FARMAC.ERFO (RK7) — Free Cash Flow Generation Index
LABORATORIO FARMAC.ERFO (RK7) has a Free Cash Flow Generation Index of -0.11x as of December 2023. Free cash flow of €-148.29K represents 0% of operating cash flow (€1.30 Million). Read total liabilities of LABORATORIO FARMAC.ERFO for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
LABORATORIO FARMAC.ERFO Free Cash Flow Generation Index (2021–2023)
Historical FCF Generation Index trend for LABORATORIO FARMAC.ERFO across 3 annual periods. Explore LABORATORIO FARMAC.ERFO (RK7) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year Free Cash Flow Generation Index for LABORATORIO FARMAC.ERFO. For the full company profile including market capitalisation, see market cap of LABORATORIO FARMAC.ERFO.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.11x | €-148.29K | €1.30 Million | €1.45 Million | ▲ +79.1% |
| 2022 | -0.55x | €-416.06K | €761.80K | €1.18 Million | ▼ -161.1% |
| 2021 | 0.89x | €2.03 Million | €2.27 Million | €242.84K | — |